The analysis of gene expression data in the RISK cohort suggests IL-23 expression despite the presence of IL-10 in a subset of patients with macroscopic inflammation and deep ulcerating IBD in the absence of Mendelian IL-10 or IL-10R loss of function DNA variants, that is, functional IL-10 resistance. The gene discussed is IL10; the disease is inflammatory bowel disease.